ATOBEST PLC-101-S

ATOBEST PLC-101-S

ATOBEST PLC-101-S Made in Korea

Description

http://youtu.be/b_XP42H3CaI BPCOSMEDI is company for cosmetics distribution of BIOPID. PLC-101 is the main ingredient of the ATOBEST lineup and this patented ingredient is developed by the BioPid Corporation. After long term study and research, the company developed a specialized care product effective on atopy, sensitive and super dry skin. The patented ingredient’s natural phospholipid vitalizes the fat metabolism beneath the skin to help rejuvenate damaged skin. Unlike the Ceramide-like moisturizing ingredients which are used to temporarily stabilize the skin, PLC-101 will vitalize the skin cells to produce Ceramide on its own to rejuvenate damaged skin.       Marketing Concept 1. Safe to use The patented compound of BioPid, the double saturated phospholipid used in the medication was proven to be safe through clinical trials. 2. Skin rejuvenation The patented compound double saturated phospholipid helps the skin produce Ceramide on its own to rejuvenate damaged skin. 3. Low skin irritation By using safe basic materials and a minimum amount of recipes, the product enables a minimum irritation level on atopy and sensitive skin. 4. Technical skills recognized World wide Registered patent for countries in Korea, Austria, Singapore, China, Japan, Russia India, Hong Kong and EU. Application for patents applied in the U.S, Canada, Brazil. 5. KFDA’s phase 3 Clinical trial completed Is the first Korean atopy medication to have completed phase 3 clinical trials at 8 university hospitals including Seoul Univ. Hospital, Yeonsei Univ. Severance Hospital, Catholic Univ. St. Mary’s Hospital, and Hanyang Univ. Hospital. 6. KFDA Registered medication On March 30th, 2011, the medication is the 17th new medication to be listed on KFDA’s new medication registration.   Product Concept 1. Applies direct effect to atopy diseased, sensitive and super dry skin. 2. Forming powerful skin protection layers to create stable conditions under outside irritation. 3. Supplies basic ingredients for Ceramide production. 4. Outstanding moisture keeping ability helps keep skin moist. 5. Very stable against lipid oxidation providing outstanding skin protection. 6. Vitalizing fat metabolism of skin cells allowing smooth and shiny skin to be maintained.   BIOPID Introduction Biopid Corporation is a bio company that was established in December 2005 for the purposes of research and development of skin disease such as atopic dermatitis, eczema, psoriasis and lung disease such as rhinitis, asthma etc. Biopid has developed novel and effective materials on atopic dermatitis It is a composition, *Composition for reducing the exudation of serum proteins* of which a key ingredient is the double-saturated phospholipid developed for treatment of rhinitis, asthma, chronic obstructive pulmonary diseases and noninfectious skin diseases such as atopic dermatitis and the patent registration has been completed in 17 countries of the world. It was approved phase 2 and 3 clinical trials as a treatment for atopic dermatitis by KFDA, and it was completed clinical trials (three-phase) at 8 Korean university hospitals for the first time in Korea in 2009. KT&G101 acquired approval of new drugs (KFDA) in nov. 2012 Also, Biopid has completed the development of cosmetics for atopic dermatitis applying the patented ingredient. Currently, it is developing functional cosmetic for anti-aging and infant. Biopid has a capital US$3.5M and affiliated companies, company for cosmetics distribution , for atopic medical tourism.   Atopy Medication Development History Feb. 2005. Application of patent for *Composition for reducing blood protein exudation* Dec. 2006. Signed transfer of technology contract with KT&G for Atopic dermatitis medication Aug. 2008. Phase 2 and 3 of clinical trials for Atopic dermatitis medication (KT&G101) approved by Korean Food and Drug Administration Jan. 2009. Initiation of KT&G 101 phase 2 and 3 clinical trials at 8 Korean university hospitals (Seoul University Hospital, Yeonsei University Severance Hospital, Catholic University of Korea Uijeongbu St. Mary Hospital, Hanyang University Hospital, Chungang University Hospital, Catholic University of Korea Incheon St. Mary Hospital. Hallym University Medical Center, Soonchunyang University Hospital) Nov. 2009. Completion of Phase 3 clinical trials of Atopic dermatitis medication (KT&G101) Jul. 2010. Composition of final report of clinical trial of Atopic dermatitis medication (KT&G101) Mar. 2011. Applied for NDA of Atopic dermatitis medication (KT&G101) at Korean Food & Drug Administration Nov. 2012 KT&G101 acquired approval of new medicine for Atopic Dermatitis (KFDA)   Patent Status *Composition for reducing the exudation of serum proteins* patent - Applicable field : Atopic dermatitis, nasal inflammation, and asthma medication and cosmetics - Patent registration : Korea (2009), Austria, Singapore, Russia (2010), China, EU (2011), Japan, India, Hong Kong (2012) - Patent evaluation : U.S, Brazil, Canada *Compound for accelerating hair growth* applied for patent - Applicable field : Hair loss prevention / hair growth - Patent application complete (May, 2010) - PCT application (May, 2011) *Patch for the treatment and relief of symptoms of skin diseases with the exudation of serum proteins* applied for patent - Applicable field : Atopic dermatitis, Eczema, Psoriasis, Erythema, Urticaria - Patent application complete (Jul, 2010) - PCT application (Jul, 2011)   ATOBEST PLC-101-S (For body, 30ml : For serious conditions)     Instructions Apply an optimal amount of “PLC-101S” to atopy and damaged skin areas and to ensure a better application, please massage the area for 15-20 seconds (2-3 times a day/ 1 drop for 4cm*4cm skin area recommended)   Please use under these circumstances! 1. When skin has lost its luster and swells up due to serious irritation 2. When skin turns deeply red and swells up 3. When skin is very rough and peels up 4. When dead skin cells form a scab and skin is chapped. 5. When skin’s exudate become solid or cornifies. 6. When serious dryness causes scratching or sores. Please check when using! 1. User must disinfect the damaged skin area prior to using the product. 2. When the area is damaged by scratching or unhealthiness, please treat the skin first before using. 3. The damaged skin area may have a 2nd infection during application. Please apply antibacterial ointment after applying this product. 4. Please do not apply to the face. 5. Only use an optimum amount. Overuse may cause trouble. Caution Using an optimum amount will have a significant effect on the skin. Using more than an optimum amount may cause adverse effects.

Product Inquiry

Your Name:
Your E-Mail:
Telephone Number:
Fax Number:
Your Country & Territory:
Address:
Subject:
Product Quantity Looking for:
Your Message:

Note: Please clealry menction the product/product names, Model, Size & other specifications that will help us to reply you as soon as possible.
Additional Details Required:
  • Minimum Order Quantity
  • Payment Terms
  • More Product Details
  • Availability / Cost
  • Shipping Details
  • Certificates
  • Expected Delivery Lead Time
Confirm Text:    captcha
 

Purchase Product Catalog

Payment & Shipping Conditions:
  • Payment: We accept payment through Paypal Only.
  • Shipping: We will ship the catalog once the payment is received. And you will be receiving the catalog with in 10 -14 busines days. Shipping might be delayed in due to international shipping conditions which is depends on the countries receiveing. In case hard copy of catalog is not available then we will ship the soft copy.
  • Refund: We can refund the order before shipping process was initiated. Incase Catalog not available, we will make sure to refund the order.
  • Note: This is a Catalog Produt.

Products Categories

Products Keywords

Share ATOBEST PLC-101-S in Social Media